Sharp Therapeutics Corp. (TSXV:SHRX)
Canada · Delayed Price · Currency is CAD 3.650
0.00 (0.00%)
At close: Oct 23, 2025
Sharp Therapeutics Statistics
Total Valuation
TSXV:SHRX has a market cap or net worth of CAD 109.53 million. The enterprise value is 107.01 million.
| Market Cap | 109.53M |
| Enterprise Value | 107.01M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:SHRX has 30.01 million shares outstanding. The number of shares has increased by 438.66% in one year.
| Current Share Class | 30.01M |
| Shares Outstanding | 30.01M |
| Shares Change (YoY) | +438.66% |
| Shares Change (QoQ) | +5.12% |
| Owned by Insiders (%) | 3.46% |
| Owned by Institutions (%) | 0.70% |
| Float | 16.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 32.69 |
| P/TBV Ratio | 32.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -26.86 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.32, with a Debt / Equity ratio of 0.53.
| Current Ratio | 6.32 |
| Quick Ratio | 6.15 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.94 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -78.86% |
| Return on Invested Capital (ROIC) | -103.58% |
| Return on Capital Employed (ROCE) | -95.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 1.28 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 63.01 |
| Average Volume (20 Days) | 4,097 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.83M |
| Pretax Income | -3.98M |
| Net Income | -3.98M |
| EBITDA | -4.86M |
| EBIT | -4.83M |
| Earnings Per Share (EPS) | -0.17 |
Balance Sheet
The company has 4.30 million in cash and 1.77 million in debt, giving a net cash position of 2.52 million or 0.08 per share.
| Cash & Cash Equivalents | 4.30M |
| Total Debt | 1.77M |
| Net Cash | 2.52M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 3.35M |
| Book Value Per Share | 0.11 |
| Working Capital | 3.71M |
Cash Flow
| Operating Cash Flow | -6.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:SHRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -438.66% |
| Shareholder Yield | -438.66% |
| Earnings Yield | -3.64% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |